Hyperammonemia and acute liver failure associated with deferasirox in two adolescents with sickle cell disease

Br J Haematol. 2023 May;201(4):e30-e33. doi: 10.1111/bjh.18770. Epub 2023 Mar 25.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Anemia, Sickle Cell* / complications
  • Anemia, Sickle Cell* / drug therapy
  • Benzoates
  • Deferasirox / adverse effects
  • Humans
  • Hyperammonemia* / chemically induced
  • Iron Chelating Agents / adverse effects
  • Liver Failure, Acute* / chemically induced

Substances

  • Deferasirox
  • Iron Chelating Agents
  • Benzoates